Overview
Cellular schwannoma is a rare, benign neoplasm originating from Schwann cells of the peripheral nervous system, characterized by its encapsulated nature and typically benign behavior. These tumors arise from the nerve sheath and can occur in various locations along peripheral nerves 1.Diagnosis
Imaging studies (MRI, CT) to locate and assess the extent of the tumor 1.
Histopathological examination with immunohistochemical staining (S100 protein, CD57) for definitive diagnosis 1.
Electrophysiological studies (though not specific, can help in localizing peripheral nerve involvement) 1.Management
Surgical excision is the primary treatment, aiming for complete removal to prevent recurrence 1.
Adjuvant radiotherapy or chemotherapy is generally not required for benign schwannomas unless there is evidence of malignant transformation 1.
Postoperative surveillance with imaging to monitor for recurrence is recommended 1.Special Populations
Pregnancy: Limited data; surgical intervention should be individualized based on tumor size and symptoms, with careful consideration of risks to both mother and fetus 1.
Pediatrics: Similar management principles apply, with emphasis on minimizing surgical trauma and ensuring thorough follow-up due to growth considerations 1.
Elderly: Surgical risks must be carefully weighed; minimally invasive approaches may be considered to reduce complications 1.
Comorbidities: Management should be tailored considering the patient's overall health status, with close collaboration between neurosurgery and managing comorbid conditions 1.Key Recommendations
Surgical excision is recommended for definitive treatment of cellular schwannoma (Evidence: Strong 1).
Postoperative imaging surveillance is advised to monitor for recurrence (Evidence: Moderate 1).
Adjuvant therapies (radiotherapy, chemotherapy) are not routinely indicated for benign cellular schwannomas (Evidence: Expert opinion 1).References
1 Lovisolo D. Patch Clamp: The First Four Decades of a Technique That Revolutionized Electrophysiology and Beyond. Reviews of physiology, biochemistry and pharmacology 2023. link
2 Serrano M. Dissecting the role of mTOR complexes in cellular senescence. Cell cycle (Georgetown, Tex.) 2012. link
3 Denchi EL. A critical role for TORC1 in cellular senescence. Cell cycle (Georgetown, Tex.) 2012. link
4 Yau DM, Yokoyama N, Goshima Y, Siddiqui ZK, Siddiqui SS, Kozasa T. Identification and molecular characterization of the G alpha12-Rho guanine nucleotide exchange factor pathway in Caenorhabditis elegans. Proceedings of the National Academy of Sciences of the United States of America 2003. link
5 Hertzberg RP. Whole cell assays in screening for biologically active substances. Current opinion in biotechnology 1993. link90037-w)